Eli Lilly accused of sham litigation in Brazil
Brazil's Administrative Council for Economic Defence (CADE) is seeking penalties against pharmaceutical company Eli Lilly after finding the company repeatedly filed lawsuits to prolong its monopoly of a cancer drug.
To read more
Subscribe to Latin Lawyer
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Latin Lawyer experts.
Subscribe now